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In this study, prostatic acid phosphatase (PAP), which is overexpressed in human
prostate cancer cells, was cloned to be fused to the IgM constant fragment (Fc)
for enhancing immunogenicity and expressed in transgenic tobacco plants. Then,
the transgenic plants were propagated by in vitro tissue subculture. Gene insertion
and expression of the recombinant PAP-IgM Fc fusion protein were confirmed in
each tested the first, second, and third subculture generations (SG1, SG2, and SG3,
respectively). Transcription levels were constantly maintained in the SG1, SG2, and SG3
leaf section (top, middle, and base ). The presence of the PAP-IgM Fc gene was also
confirmed in each leaf section in all tested subculture generations. RNA expression was
confirmed in all subculture generations using real-time PCR and quantitative real-time
PCR. PAP-IgM Fc protein expression was confirmed in all leaves of the SG1, SG2,
and SG3 recombinant transgenic plants by using quantitative western blotting and
chemiluminescence immunoassays. These results demonstrate that the recombinant
protein was stably expressed for several generations of in vitro subculture. Therefore,
transgenic plants can be propagated using in vitro tissue subculture for the production
of recombinant proteins.
Keywords: subculture generation, propagation, transgenic plant, recombinant protein, prostatic acid
phosphatase
BACKGROUND
Recombinant proteins are commonly produced in animal cells (Andersen and Krummen, 2002;
Birch and Racher, 2006). However, production in animal cells is costly, and the cultures are
susceptible to human pathogen contamination. Plants have also been effectively used as expression
systems for large-scale production of recombinant proteins (Larrick and Thomas, 2001; Twyman
et al., 2003; Fischer et al., 2004; Daniell et al., 2009; Ko et al., 2009; So et al., 2013; Lim et al.,
2015; Park et al., 2015; Kim et al., 2016), and plant-based production has many advantages
over other systems, including low biomass production costs and lack of human pathogen
contamination (Twyman et al., 2003). Therefore, a wide range of recombinant biotherapeutic
proteins, including industrial enzymes and new protein polymers, have been produced in plants
(Ma et al., 2003). Similar to mammalian cell expression systems, plant biomass increases in an
in vitro subculture system, and subculture can affect the protein expression level (Kim et al., 2011;
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Dorai and Ganguly, 2014). Although in vitro plant tissue
subculture is an efficient method for clonal propagation,
somaclonal variation generation occurred after quite prolong
stage of unorganized growth, with a loss of transgene insertion
and protein expression (Krishna et al., 2016). The recombinant
proteins must be stably expressed in plants during in vitro
growth so that the protein product can be extracted and purified.
However, loss of the recombinant protein during plant tissue
subculture is unpredictable, and sometimes, recombinant protein
expression is unstable.
Prostatic acid phosphatase (PAP) is a glycoprotein that is
synthesized in the epithelial cells of the prostate and is secreted
into the seminal fluid (Vihko et al., 1988; McNeel et al., 2009).
PAP is a prostate cancer antigen that is overexpressed by
malignant prostate cell tissues and is often used as a therapeutic
protein (Tarassoff et al., 2006; McNeel et al., 2009; Saif et al.,
2014). In addition, due to its high expression in the prostate,
PAP has been tested as a prostate cancer target antigen (Graddis
et al., 2011). PAP-based peptide vaccination has been reported
to induce antigen-specific T-cell responses and inhibit tumor
growth in mice (Saif et al., 2014).
In this study, we examined the expression of a PAP-IgM Fc
fusion protein in plant leaves from in vitro tissue subculture,
as a vaccine candidate. The aim of this study was to determine
whether PAP-IgM Fc fusion protein expression is stable over
several in vitro subculture generations (SG1, SG2, and SG3).
MATERIALS AND METHODS
Construction of the PAP-IgM Fc Gene
Expression Vector
The synthetic DNA sequence encoding PAP (GenBank
accession no. M34840.1) was cloned as a fusion to the Fc
fragment of the human IgM µ chain (GenBank accession
No. X57086.1). The PAP sequence was modified by the
addition of an N-terminal extension encoding a signal peptide
(MATQRRANPSSLHLITVFSLLAAVVSAEVD; Lu et al., 2012).
The gene encoding PAP-IgM Fc was cloned under the control of
the enhanced cauliflower mosaic virus (CaMV) 35S promoter
and the tobacco etch virus 5’-leader sequence (TEV; Figure 1A).
The PAP-IgM Fc expression cassette was subcloned into the
HindIII and EcoRI restriction enzyme sites of the binary plant
expression vector pBI121 to generate pBI PAP-IgM Fc. Then, the
vector was transformed into competent Escherichia coli DH5α
cells for amplification.
Plant Transformation
The recombinant pBI PAP-IgM Fc vector was transferred into
Agrobacterium tumefaciens strain LBA4404 by electroporation.
Then, transgenic tobacco (Nicotiana tabacum) plants were
generated by Agrobacterium-mediated transformation (Ko et al.,
2003; Lu et al., 2012; So et al., 2013). Transgenic plant lines
were selected on Murashige and Skoog (MS) medium [30 g·L−1
of Sucrose, 6 g·L−1 of Phyto agar, and 4.8 g·L−1 of MS B5
vitamin (Duchefa Biochemie, Haarlem, Netherlands)] containing
100 mg·L−1 kanamycin and 250 mg·L−1 cefotaxime. Transgenic
plants were grown in a chamber at constant temperature (23◦C)
and light intensity of 50 µmol·m−2·s−1 under a long-day
photoperiod (16:8 h light-dark cycle). Among the transgenic
plants with high protein expression, three PAP-IgM Fc expressing
transgenic lines (T502, T506, and T509) were randomly selected
for in vitro tissue subculture.
In vitro Subculture of PAP-IgM Fc Plants
Transgenic plants expressing PAP-IgM Fc were grown in vitro as
the first generation tissue culture (SG1) in a Magenta GA-7 vessel
(Sigma–Aldrich, St. Louis, MO, USA) for 4 weeks. Plant stems
were divided into three sections [top (T), middle (M), and base
(BA)]. T, M, and BA plantlet stem pieces were transplanted into
new media and grown as the second-generation tissue subculture
(SG2) for 2 weeks. This tissue subculture was repeated to generate
the third generation SG3 (Figure 1A).
Genomic DNA Extraction and PCR
Analysis
Leaf tissue samples were harvested from the top portion
of transgenic and non-transgenic plantlets. Genomic DNA
from fresh leaf tissue was isolated using a DNA extraction
kit (RBC Bioscience, Seoul, South Korea) according to the
manufacturer’s protocol. The extracted genomic DNA was
analyzed by polymerase chain reaction (PCR) to confirm the
presence of the recombinant PAP-IgM Fc gene using the
following primer pairs: forward primer 5′-GCC CTC GTT TTC
AAG AAC TTG-3′ and reverse primer 5′-CGG GAT CCT CAG
TAG CAG GTG CCA GCT GTG-3′. The PCR was performed
with 30 cycles of 94◦C for 20 s, 62◦C for 20 s, and 72◦C for
120 s. Genomic DNA isolated from non-transgenic plant leaves
was used as the negative control, and the pBI PAP-IgM Fc gene
was used as a positive control. The expected size of PAP-IgM Fc
PCR product was 1,685 bp. PCR analysis was performed for more
than three times.
Real Time-PCR (RT-PCR) and
Quantitative Real Time-PCR (RT-qPCR)
Analyses
Leaf tissue samples were used from each top portion of transgenic
plantlets. Total RNA was isolated from the leaves of transgenic
plant samples (SG1, SG2, and SG3) using an Rneasy plant mini
kit (Quagen, Valencia, CA) according to the manufacturer’s
recommendations, and the isolated RNA samples were stored
at -80◦C. Genomic DNA removal and cDNA synthesis were
performed using the Quantitect reverse transcription kit
(Quagen, Valencia, CA) according to the manufacturer’s protocol.
Each RNA sample was used as a template for RT-PCR and
RT-qPCR analyses. RT-PCR and RT-qPCR reactions were
performed using the Maxime PCR premix kit (Intron
Biotechnology, Seoul, South Korea) and Rotor-Gene SYBR
Green PCR kit (Quagen, Valencia, CA), respectively. PAP-IgM
Fc primers were as follows: 5′-CTC ATG CTA CCT GGT TGC
AG-3′; forward, 5′-GGT GGG ACG AAG ACG CTC A-3′.
Quantitative RT-PCR was analyzed using real-time PCR machine
(Rotor-Gene Q, Quagen) with the following cycling parameters:
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FIGURE 1 | Schematic diagram of the plant expression vector, the structure of the recombinant prostatic acid phosphatase (PAP)-IgM Fc fusion
protein, plant transformation procedure, and sampling procedure for top, middle, and base leaf tissues in the various subculture generations (SG1,
SG2, and SG3). (A) The PAP-IgM Fc gene expression cassette in the binary pBI121 plant vector containing the cauliflower mosaic virus 35S promoter with a
duplicated enhancer region (E/35S-P), the untranslated leader sequence of the tobacco etch virus, and the nopaline synthase gene terminator (NOST). Expected
structure of the recombinant PAP-IgM Fc fusion protein, with a spring-shaped region (PAP) and a gray oval region (IgM Fc). A PAP-IgM Fc transgenic tobacco
(Continued)
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FIGURE 1 | Continued
plantlet growing on kanamycin selection medium in a Magenta GA-7 vessel. T, top SG1 stem sample; M, middle SG1 stem sample; BA, base SG1 stem sample;
T-T’, T of the SG2 stem produced from the T of the SG1 stem; T-M’, M of the SG2 stem produced from the T of the SG1 stem; T-BA’, BA of the SG2 stem produced
from the T of the SG1 stem; M-T’, T of the SG2 stem produced from the M of the SG1 stem; M-M’, M of the SG2 stem produced from the M of the SG1 stem;
M-BA’, BA of the SG2 stem produced from the M of the SG1 stem; BA-T’, T of the SG2 stem produced from the BA of the SG1 stem; BA-M’, M of the SG2 stem
produced from the BA of the SG1 stem; and BA-BA’, BA of the SG2 stem produced from the BA of the SG1 stem. The circle with the dotted line indicates the part of
the leaf tissue of the top portion that was harvested for analyses. (B) polymerase chain reaction (PCR) analysis to confirm the presence of the PAP-IgM Fc gene in
tissues from subculture generations SG1, SG2, and SG3. PAP-IgM Fc (1,786 bp): positive control (+), pBI PAP-IgM Fc recombinant vector in DH5α competent cells,
negative control (−), and non-transgenic tobacco plant (NT). The loading amount was 5 µL per sample. (C) Reverse transcription (RT)-PCR. Gene expressions were
analyzed using RT-PCR of SG1, SG2, and SG3 leaf section. The negative control (−) consists of mRNA of a non-transgenic tobacco plant. The EF-1α gene was
used as a housekeeping gene.
5 min at 95◦C, 5 s at 95◦C, 10 s at 60◦C, and 40 cycles of 5 s at
95◦C and 10 s at 60◦C. The elongation factor 1-α (EF-1α) gene
was used as a housekeeping gene. RT PCR and RT-qPCR analyses
were performed for 3 times.
Quantitative Immunoblot Analysis
The PAP-IgM Fc protein expression level in transgenic lines T502,
T506, and T509 was investigated using immunoblot analysis.
Leaf samples (100 mg) were harvested from the plantlet top and
homogenized in 300 µL of 1 × PBS (137 mM NaCl, 10 mM
Na2HPO4, 2.7 mM KCl, and 2 mM KH2PO4) to extract total
soluble proteins. PAP-IgM Fc leaf extracts were boiled with
5× protein loading buffer (1 M Tris-HCl, 50% glycerol, 10% SDS,
5% 2-mercaptoethanol, and 0.1% bromophenol blue) for 10 min
and cooled for 2 min. Total soluble proteins were separated by
10% SDS-PAGE and transferred to a nitrocellulose membrane
(Millipore, Billerica, MA, USA). Membranes were incubated with
5% skim milk (Sigma, St. Louis, MO, USA) in 1 × PBS buffer
at 4◦C overnight. Blots were incubated with a goat anti-human
IgM (µ chain) antibody conjugated to horseradish peroxidase
(Abcam Inc., Cambridge, MA, USA) diluted 1:5,000 in 1 × PBS
solution for 2 h at room temperature (Figure 2A). After three 10-
min washes, proteins were detected with the SuperSignal West
Pico Chemiluminescent Substrate (Thermo Scientific, Rockford,
IL, USA) and visualized by exposing the membrane to X-ray
film (Fuji, Tokyo, Japan). Leaf tissue extract from non-transgenic
plants was used as a negative control. Detected protein bands
were digitized as an electronic image, and band intensity was
measured using ImageJ software (National Institutes of Health,
Bethesda, MD, USA). Immunoblot analysis was performed for
more than three times.
Chemiluminescence Immunoassay
Expression of PAP-IgM Fc in plant leaf tissue was analyzed using
a chemiluminescence immunoassay (CLIA). Leaf samples from
PAP-IgM Fc transgenic plants were harvested from the plantlet
top (T of SG2 and T-T’, M-T’, and BA-T’ of SG3; Figure 1A)
and homogenized in 300 µL of 1 × PBS (137 mM NaCl,
10 mM Na2HPO4, 2.7 mM KCl, and 2 mM KH2PO4) for total
soluble protein extraction. All samples were diluted 1:100 in
1 × PBS solution. A cuvette containing the anti-PAP coated
beads (Siemens Healthcare Diagnostics Inc., Llanberis, UK) was
incubated with PAP-IgM Fc and an anti-PAP antibody conjugated
to alkaline phosphatase for 30 min at 37◦C (Figure 2F). After
the antibodies were removed and the beads were washed in
deionized distilled water as a centrifugal washing buffer, the
PAP-IgM Fc proteins were detected using the chemiluminescent
substrate. The samples were analyzed on an IMMULITE 2000 xpi
(Siemens Healthcare Diagnostic Inc., Flanders, NJ, USA). CLIA
was performed for more than three times.
Statistical Analysis
All values are shown as the mean ± SD. Recombinant PAP-IgM
Fc protein expression in transgenic plant leaves was compared
by using the unpaired t-test, and p values less than 0.01 (∗∗∗)
or 0.05 (∗∗) were considered statistically significant. Statistical
significance was assessed using Excel (Microsoft Office Excel
2013; Microsoft Corporation, Redmond, WA, USA).
RESULTS
Confirmation of PAP-IgM Fc Gene
Presence
Transgenic tobacco plant lines were obtained by Agrobacterium-
mediated transformation with plant expression vectors carrying
PAP-IgM Fc. Genomic DNA extracted from three transgenic
lines (T502, T506, and T509) was analyzed by PCR to confirm
insertion of the PAP-IgM Fc transgene. The PAP-IgM Fc gene
was detected in the top leaves of each subculture generation (SG1,
SG2, and SG3) obtained from the T, M, and BA stems harvested
from tobacco transgenic plants (SG1). The size of the PAP-IgM
Fc PCR product in the genome of the transgenic plants was
1,685 bp (Figure 1B). No PAP-IgM Fc PCR product was detected
in non-transgenic plants.
Gene Transcription Level Analysis of
PAP-IgM Fc in All Subculture
Generations (SG1, SG2, and SG3)
In real-time PCR and quantitative real-time PCR, the relative
transcription level was observed in the top portions of all
subculture generations (SG1, SG2, and SG3) leaf tissues
(Supplementary Figure S1). The transgene was not detected
in non-transgenic plant (Figure 1C). RT-PCR product of
the expected size of PAP-IgM Fc was detected in all samples
of transgenic plants (T502, T506, and T509; Figure 1C). In
RT-qPCR, the PAP-IgM Fc transcriptional levels were
consistently higher than 0.9 level in SG1, SG2, and SG3
leaf section (T, M, and BA; Supplementary Figure S1).
Non-transgenic plant showed no PAP-IgM Fc signal.
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FIGURE 2 | Densitometry analysis of PAP-IgM Fc protein expression levels in the tissues of plantlets from subculture generations SG1, SG2, and SG3
(A–E) and chemiluminescence immunoassay (CLIA) to confirm PAP-IgM Fc protein expression in various leaf tissues from subculture (T of SG2 and T-T, M-T’, and
BA-T’ of SG3 protein expression SG3 (F–I). (A) Illustration showing the interaction between PAP-IgM Fc and the anti-human IgM antibody conjugated to horseradish
peroxidase (HRP) in the western blot. (B) Western blot analysis to confirm PAP-IgM Fc protein expression in top (T), middle (M), and base (BA) stem tissues from
different subculture generations (SG1, SG2, and SG3). Negative control (–) and non-transgenic plant (NT). PAP-IgM Fc (83 kDa) was detected with HRP-conjugated
goat anti-human IgM (µ chain) immunoglobulin. Black arrowheads indicate the PAP-IgM Fc protein band (83 kDa). Expression levels of PAP-IgM Fc in T502 (C), T506
(D), and T509 (E) leaf tissues were assessed by western blotting with an anti-human IgM (µ chain) immunoglobulin conjugated to HRP. Protein expression rates in
the three PAP-IgM Fc transgenic lines were calculated based on the protein band density in the western blot analysis. (F) Illustration of the double sandwich CLIA.
The interaction between PAP-IgM Fc and the anti-human IgM antibody conjugated to alkaline phosphatase. The expression in the transgenic lines T502 (G), T506
(H), and T509 (I) PAP-IgM Fc proteins in transgenic plants from the top of SG2 and SG3. Data are the mean and standard error (∗∗∗p < 0.01, ∗∗p < 0.05, t-test).
Confirmation of PAP-IgM Fc Protein
Expression
PAP-IgM Fc protein expression in leaf samples from transgenic
plants was analyzed by western blotting. All transgenic plant lines
harboring the PAP-IgM Fc transgene showed a protein band of
approximately 83 kDa (Figure 2B). Recombinant PAP-IgM Fc
fusion proteins were expressed in all subculture generations (SG1,
SG2, and SG3) obtained from the T, M, and BA stems of SG1
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transgenic plants (Figure 2B). No PAP-IgM Fc protein band was
detected in non-transgenic plants, which were used as a negative
control (Figure 2B).
Densitometry Analysis of PAP-IgM Fc
Protein Expression Levels in SG1, SG2,
and SG3
Quantitative western blot analysis was performed to determine
the expression level of the recombinant PAP-IgM Fc fusion
protein in the top leaves of SG1, SG2, and SG3 (Figure 2B).
The intensity of the PAP-IgM Fc fusion protein bands in
the top leaf samples was quantified using Image J software.
Although the PAP-IgM Fc recombinant protein expression level
differed slightly among the SG1, SG2, and SG3 samples, all leaf
samples showed stable expression of the recombinant protein
(Figures 2C–E).
Quantitative CLIA of PAP-IgM Fc in
Transgenic Plant Leaves
A CLIA was performed to quantify the expression of recombinant
PAP-IgM Fc protein in the transgenic leaves of SG2 and SG3
plants. In T502, PAP-IgM Fc expression levels in each leaf
position were slightly different. However, the mean values at
each position in SG3 were not significantly different (Figure 2G).
In T506, the PAP-IgM Fc expression levels were significantly
different at each leaf position, and the mean values at each
position in SG3 were significantly different (Figure 2H). In T509,
the PAP-IgM Fc expression levels in SG2, T-T’ of SG3, and M-T-
of SG3 differed. However, the mean values at all positions were
not significantly different (Figure 2I). Overall, the expression
of the recombinant PAP-IgM Fc fusion protein was maintained
without loss in all in vitro SG samples (Figures 2G–I).
DISCUSSION
This study demonstrated that the production of different
subculture generations of transgenic plants did not affect the
expression of the recombinant PAP-IgM Fc fusion protein. The
fusion of antigenic protein to IgM Fc can assembled to form large
quaternary circular protein enhancing immunogenicity (David
et al., 2011). The PAP is a PAP glycoprotein fused to the Fc
fragment of the human IgM immunoglobulin. The PAP-IgM
Fc gene was constitutively expressed under the control of the
enhanced CaMV 35S promoter (Lu et al., 2012; Lim et al., 2015).
The N-terminus of PAP was fused to a signal peptide.
In this study, we hypothesized that PAP-IgM Fc expression
in transgenic plants would be stable through several generations
produced by in vitro tissue subculture. With this in mind, each
cultured stem section (T, M, and BA) was transplanted and
grown to investigate the stability of the transgene insertion
and transgenic protein expression. PCR analysis confirmed that
the recombinant PAP-IgM Fc gene insertion was stable in all
tested subculture generations (SG1, SG2, and SG3). In vitro
subcultured transgenic plants may lose the recombinant gene
during propagation (Fladung and Kumar, 2002; Zeng et al.,
2010; Martinelli et al., 2015). Loss of recombinant genes may
occur because they are not strongly attached to the genomic
DNA of plant cells (Doran, 2006). However, in this study,
stable insertion of the PAP-IgM Fc gene was confirmed in
all subculture generations. RT-PCR and RT-qPCR analysis
were applied to investigate whether the mRNA levels of the
PAP-IgM Fc gene expression at all subculture generations (SG1,
SG2, and SG3). The mRNA levels slightly differed at each
subculture generations. However, transcription levels in all
transgenic plants were constantly maintained at each subculture
generation (Supplementary Figure S1). These results indicate
that the PAP-IgM Fc transgene was not deleted during tissue
propagation.
Immunoblot analysis and CLIA were conducted to investigate
whether the PAP-IgM Fc fusion protein was expressed in the
different subculture generations. The protein expression levels
slightly differed at leaf tissue positions among SG1, SG2, and
SG3. Such of the PAP-IgM Fc protein level is due to leaf tissue
position and developmental stage, at which water content and
plant cell number might be variable (Streatfield, 2007; Lim
et al., 2015). Thus, in the future normalization for protein
level quantification should be optimized, which can precisely
calculate amount of recombinant protein per amount of total
soluble protein in plant tissue (Alkanaimsh et al., 2016). In
addition, the protein level might be fluctuated by variation
factors, which are total soluble protein levels to be hardly
controlled because of low ratio between leaf tissue material weight
and homogenizing buffer volume in this study. However, all leaf
samples harvested from the top portion of the plants showed
stable expression of the PAP-IgM Fc recombinant protein. In
addition, the PAP-IgM Fc recombinant protein was expressed
without degradation in a consistent pattern in all subculture
generations (SG1, SG2, and SG3). The PAP expression levels
in each plant sample, as quantified by western blotting, were
correlated with the PAP levels detected by CLIA (data not
shown). This shows that both these quantitative methods are
reliable for confirming PAP expression in transgenic plant
tissues.
Plant expression systems are advantageous both in terms of
safety and production cost, when compared to conventional cell
systems, such as yeast, mammalian, and insect cells (Twyman
et al., 2003; Ko, 2014). In animal cell systems, loss of recombinant
protein expression often occurs during subculture due to deletion
of the recombinant transgenes (Heller-Harrison et al., 2009; Kim
et al., 2011; Dorai and Ganguly, 2014).
The ultimate purpose of in vitro plant tissue subculture is
the mass propagation of transgenic plants. However, somatic
variations that occur during in vitro subculture can alter
the genetic components and protein expression. Therefore,
expression of the recombinant protein in the transgenic plants
must be confirmed through in vitro subculture.
Taken together, the transgenic plants obtained through in vitro
tissue subculture showed that the transgene and transgenic
protein expression were stable. Thus, transgenic plants can
be used to produce highly valuable therapeutic recombinant
proteins via in vitro subculture. PAP is highly expressed in human
prostate cancer cells, which can be a promising vaccine candidate.
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In addition, PAP itself can be used as one of prostate cancer
indicators in medical diagnosis. Thus, plant-derived recombinant
PAP-IgM Fc fusion protein can be highly useful in both research
medical and purposes.
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